80 Views | 27 Downloads
Jordan Gilleland Marchak, PhD, ABPP; Aflac Cancer and Blood Disorders Center, 2015 Uppergate Dr, Atlanta, Georgia, 30322, USA; Phone: +1-404-727-2293. Email: jgillel@emory.edu
We thank the survivors’ representatives Clarissa Schilstra (Australia), Michael S. Taccone (founder and survivor representative of Childhood Cancer Survivor Canada), and Jaap den Hartogh, Zuzana Tomášiková, and Carina Schneider from CCI Europe for their critical and valuable appraisal of the recommendations. Additionally, we would like to thank Kristen Coros for her support with the search update and Divine Kalenda for her support with manually searching the reference lists of included articles. We would also like to thank the complete IGHG psychological late effects group and Satomi Sato Funaki for their expert review of the recommendations.
We declare no conflicts of interest.
This work was supported by the Krebsliga Zentralschweiz, the Swiss National Science Foundation (Grant No. 10001C_182129/1 and 100019_153268 / 1) and the European Union’s Seventh Framework Programme for research, technological development, and demonstration, under grant agreement number 257505.
This work was supported (in part) by the Intramural Research Program of the NIH (LW). CW is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (APP1143767).
The funding sources had no influence in the collection, analysis, and interpretation of the data, nor in the writing of the manuscript and in the decision to submit this paper for publication.